Updated
NRX PharmaceuticalsNRXP · Healthcare
$2.34-1.68%
Market cap$101M
IndustryBiotechnology
NRX Pharmaceuticals (NRXP) Superinvestor holders
3 of the superinvestors we track hold NRX Pharmaceuticals (NRXP) in their latest 13F filings, $1M in total.
Summary
The largest holder is Paul Marshall (Marshall Wace), with $795,831, 0.0% of the portfolio.
In their latest quarter: 3 opened a new position.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Paul Marshall Marshall Wace |
New position | 194,580 | $795,831 | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
New position | 38,600 | $157,874 | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
New position | 26,429 | $108,095 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 3 |
| Q4 2025 | 2 |
| Q3 2025 | 3 |
| Q2 2025 | 2 |
| Q1 2025 | 2 |
Questions about NRX Pharmaceuticals
Which superinvestors own NRX Pharmaceuticals?
3 of the superinvestors we track hold NRX Pharmaceuticals (NRXP) in their latest 13F filings, $1M in total. Paul Marshall, Jim Simons, Two Sigma.
Who is the largest superinvestor holder of NRXP?
The largest holder is Paul Marshall (Marshall Wace), with $795,831, 0.0% of the portfolio.
From NRX Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.